Newsroom

News

LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...

Mar 26, 2019

more +
News

LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...

Sep 8, 2020

more +
Publications

Discovering the Therapeutic Potential of Keystone Bacteria in Treating Chronic Diseases

Apr 22, 2020

more +
News

LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent...

Apr 15, 2020

more +
News

LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial

Mar 12, 2020

more +
Events

IHMC Congress 2020

Jan 30, 2020

more +
Events

Bio International Convention (8-11 June 2020, San Diego)

Jan 30, 2020

more +

LNC Therapeutics © 2020 - all rights reserved terms and conditions